MedPharm has launched its Scientific Advisory Committee, headed by company founder and Board member, Professor Marc Brown. Marc Brown has served as MedPharm’s Chief Scientific Officer for over 20 years and will be stepping down from his CSO role to chair the newly formed committee.
The Scientific Advisory Committee will ensure that MedPharm continues to provide its clients with industry leading scientific services and access to beneficial strategic alliances. In addition to his role as committee chair, Brown will continue to provide technical as well as client support when required and remains a Board Director.
Dr. Jon Lenn will take over the role of CSO, with responsibility for MedPharm’s global scientific operations. Dr. Lenn is an authority in the development and optimization of topical products and has played a role in MedPharm's growth as well as the development of the Durham, NC site. More recently as Chief Technology Officer, Dr. Lenn has guided the Innovation Team in the development of biological models and performance testing tools and supported client’s needs.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
“I would like to thank Marc for what he has accomplished as MedPharm’s scientific leader, and I am pleased that despite wanting to move away from day-to-day operations he has elected to remain engaged with MedPharm’s platform in a manageable fashion. With his support as chair of the Scientific Advisory Committee, we will continue our pioneering standard and remain the world leader in the topical and transdermal CDMO field,” said Eugene Ciolfi, President & CEO. “Jon is the perfect individual to step into the CSO role. His unparalleled experience across both MedPharm and the Pharma industry will ensure our continued excellence in the science undertaken at MedPharm.”